HemaSphere (Aug 2023)
P1413: DOES TOCILIZUMAB INCREASE THE RISK OF INFECTIONS IN PATIENTS UNDERGOING CAR-T THERAPY?
- Sophie Greenhalgh,
- Mona Asslan,
- Fiona Dignan,
- Shahid Iqbal,
- Jane Norman,
- Mahmoud Bokhary,
- Lourdes Calvente Rubio,
- Elizabeth Davies,
- Mark Henry,
- Katie Brice,
- Lindsey Mannion,
- Eleni Tholouli
Affiliations
- Sophie Greenhalgh
- 1 Manchester University NHS Foundation Trust, Clinical hematology, Manchester, United Kingdom
- Mona Asslan
- 1 Manchester University NHS Foundation Trust, Clinical hematology, Manchester, United Kingdom
- Fiona Dignan
- 1 Manchester University NHS Foundation Trust, Clinical hematology, Manchester, United Kingdom
- Shahid Iqbal
- 1 Manchester University NHS Foundation Trust, Clinical hematology, Manchester, United Kingdom
- Jane Norman
- 1 Manchester University NHS Foundation Trust, Clinical hematology, Manchester, United Kingdom
- Mahmoud Bokhary
- 1 Manchester University NHS Foundation Trust, Clinical hematology, Manchester, United Kingdom
- Lourdes Calvente Rubio
- 1 Manchester University NHS Foundation Trust, Clinical hematology, Manchester, United Kingdom
- Elizabeth Davies
- 1 Manchester University NHS Foundation Trust, Clinical hematology, Manchester, United Kingdom
- Mark Henry
- 1 Manchester University NHS Foundation Trust, Clinical hematology, Manchester, United Kingdom
- Katie Brice
- 1 Manchester University NHS Foundation Trust, Clinical hematology, Manchester, United Kingdom
- Lindsey Mannion
- 1 Manchester University NHS Foundation Trust, Clinical hematology, Manchester, United Kingdom
- Eleni Tholouli
- 1 Manchester University NHS Foundation Trust, Clinical hematology, Manchester, United Kingdom
- DOI
- https://doi.org/10.1097/01.HS9.0000972540.84358.45
- Journal volume & issue
-
Vol. 7
p. e8435845
Abstract
No abstracts available.